🎯 check AMD3100 (Plerixafor) product page
AMD3100 (Plerixafor) is a potent CXCR4 antagonist. It affects PI3K/AKT pathways by blocking CXCL12, inhibiting cell migration.
AMD3100 (Plerixafor): Mechanism of Action
AMD3100 (Plerixafor) MOA：Targeting CXCR4/CXCL12 for Oncology and Cancer Immunotherapy
Jump to
- AMD3100 (Plerixafor) Clinical Trials
- AMD3100 (Plerixafor): Selectivity & Specificity
- AMD3100 (Plerixafor) Working Concentration | Cell Culture | Treatment
- AMD3100 (Plerixafor) Solubility in DMSO
- AMD3100 (Plerixafor) Stock Solution
- AMD3100 (Plerixafor) Storage
- AMD3100 (Plerixafor) Stability
- AMD3100 (Plerixafor) Combination Database
- AMD3100 (Plerixafor) Molecular Weight
- AMD3100 (Plerixafor) SMILES
- AMD3100 (Plerixafor) CAS Number
- AMD3100 (Plerixafor) Chemical Structure (2D and 3D)
- AMD3100 (Plerixafor) IC50 for Cell-based and Cell-free Assays
- AMD3100 (Plerixafor) Sigma (1545135)? Try a better option.
- AMD3100 (Plerixafor) MedChemExpress (HY-10046)? Try a better option.
- AMD3100 (Plerixafor) Cayman (35579)? Try a better option.
- AMD3100 (Plerixafor) APExBIO (A2025)? Try a better option.
- AMD3100 (Plerixafor) SDS｜MSDS